Table of Content


Introduction
Liver Failure (Hepatic Insufficiency) - Overview
Liver Failure (Hepatic Insufficiency) - Therapeutics Development
Liver Failure (Hepatic Insufficiency) - Therapeutics Assessment
Liver Failure (Hepatic Insufficiency) - Companies Involved in Therapeutics Development
Liver Failure (Hepatic Insufficiency) - Drug Profiles
Liver Failure (Hepatic Insufficiency) - Dormant Projects
Liver Failure (Hepatic Insufficiency) - Discontinued Products
Liver Failure (Hepatic Insufficiency) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Liver Failure (Hepatic Insufficiency), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Liver Failure (Hepatic Insufficiency), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Arch Biopartners Inc, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Bristol-Myers Squibb Co, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by EA Pharma Co Ltd, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by HepaRegeniX GmbH, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Hepatx Corp, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Immune Pharmaceuticals Inc, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Mallinckrodt Plc, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Martin Pharmaceuticals Inc, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Mina Therapeutics Ltd, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Mylan NV, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by PledPharma AB, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Promethera Biosciences SA, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Proterris Inc, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Rejuvenation Technologies Inc, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by RHEACELL GmbH & Co KG, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Steminent Biotherapeutics Inc, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Takeda Pharmaceutical Co Ltd, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Tianjin Weikai Bioeng Ltd, H1 2020
Liver Failure (Hepatic Insufficiency) - Pipeline by Unicyte AG, H1 2020
Liver Failure (Hepatic Insufficiency) - Dormant Projects, H1 2020
Liver Failure (Hepatic Insufficiency) - Dormant Projects, H1 2020 (Contd..1), H1 2020
Liver Failure (Hepatic Insufficiency) - Discontinued Products, H1 2020